Identification of drug-resistant subpopulations in canine hemangiosarcoma

A. Khammanivong; B. H. Gorden; A. M. Frantz; A. J. Graef; E. B. Dickerson

doi:10.1111/vco.12114

Identification of drug-resistant subpopulations in canine hemangiosarcoma

A. Khammanivong, B. H. Gorden, A. M. Frantz, A. J. Graef, E. B. Dickerson

Veterinary Clinical Sciences

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Canine hemangiosarcoma is a rapidly progressive disease that is poorly responsive to conventional chemotherapy. Despite numerous attempts to advance treatment options and improve outcomes, drug resistance remains a hurdle to successful therapy. To address this problem, we used recently characterized progenitor cell populations derived from canine hemangiosarcoma cell lines and grown as non-adherent spheres to identify potential drug resistance mechanisms as well as drug-resistant cell populations. Cells from sphere-forming cultures displayed enhanced resistance to chemotherapy drugs, expansion of dye-excluding side populations and altered ATP-binding cassette (ABC) transporter expression. Invasion studies demonstrated variability between cell lines as well as between sphere and monolayer cell populations. Collectively, our results suggest that sphere cell populations contain distinct subpopulations of drug-resistant cells that utilize multiple mechanisms to evade cytotoxic drugs. Our approach represents a new tool for the study of drug resistance in hemangiosarcoma, which could alter approaches for treating this disease.

Original language	English (US)
Pages (from-to)	e113-e125
Journal	Veterinary and Comparative Oncology
Volume	14
Issue number	3
DOIs	https://doi.org/10.1111/vco.12114
State	Published - Sep 1 2016

Bibliographical note

Funding Information:
This work was partially supported by the Office of the Vice President for Research, University of Minnesota, award #21873 (E. B. D.), a Comparative Medicine Signature Program Pilot Grant through the University of Minnesota College of Veterinary Medicine (E. B. D.), and Morris Animal Foundation D13CA-0062 (E. B. D.). A. M. F. was supported by the DVM/PhD combined degree program of the College of Veterinary Medicine, University of Minnesota, by Morris Animal Foundation pre-doctoral fellowship D09CA-405, in part by funds from the Animal Cancer Care and Research Program, University of Minnesota, and by a doctoral dissertation fellowship from the Graduate School, University of Minnesota. This work also was supported in part by NIH P30 CA77598 utilizing the University Flow Cytometry Resource. Thanks to Jaime F. Modiano and Leslie C. Sharkey for the critical reading of this manuscript.

Publisher Copyright:
© 2014 John Wiley & Sons Ltd

Keywords

ABC transporter
canine
drug resistance
hemangiosarcoma
side population

Publisher link

10.1111/vco.12114

http://europepmc.org/articles/pmc5712213

Find It

Find It at U of M Libraries

Cite this

@article{0c2f993dd2ee4379bf29104ee5a14342,

title = "Identification of drug-resistant subpopulations in canine hemangiosarcoma",

abstract = "Canine hemangiosarcoma is a rapidly progressive disease that is poorly responsive to conventional chemotherapy. Despite numerous attempts to advance treatment options and improve outcomes, drug resistance remains a hurdle to successful therapy. To address this problem, we used recently characterized progenitor cell populations derived from canine hemangiosarcoma cell lines and grown as non-adherent spheres to identify potential drug resistance mechanisms as well as drug-resistant cell populations. Cells from sphere-forming cultures displayed enhanced resistance to chemotherapy drugs, expansion of dye-excluding side populations and altered ATP-binding cassette (ABC) transporter expression. Invasion studies demonstrated variability between cell lines as well as between sphere and monolayer cell populations. Collectively, our results suggest that sphere cell populations contain distinct subpopulations of drug-resistant cells that utilize multiple mechanisms to evade cytotoxic drugs. Our approach represents a new tool for the study of drug resistance in hemangiosarcoma, which could alter approaches for treating this disease.",

keywords = "ABC transporter, canine, drug resistance, hemangiosarcoma, side population",

author = "A. Khammanivong and Gorden, {B. H.} and Frantz, {A. M.} and Graef, {A. J.} and Dickerson, {E. B.}",

note = "Funding Information: This work was partially supported by the Office of the Vice President for Research, University of Minnesota, award #21873 (E. B. D.), a Comparative Medicine Signature Program Pilot Grant through the University of Minnesota College of Veterinary Medicine (E. B. D.), and Morris Animal Foundation D13CA-0062 (E. B. D.). A. M. F. was supported by the DVM/PhD combined degree program of the College of Veterinary Medicine, University of Minnesota, by Morris Animal Foundation pre-doctoral fellowship D09CA-405, in part by funds from the Animal Cancer Care and Research Program, University of Minnesota, and by a doctoral dissertation fellowship from the Graduate School, University of Minnesota. This work also was supported in part by NIH P30 CA77598 utilizing the University Flow Cytometry Resource. Thanks to Jaime F. Modiano and Leslie C. Sharkey for the critical reading of this manuscript. Publisher Copyright: {\textcopyright} 2014 John Wiley & Sons Ltd",

year = "2016",

month = sep,

day = "1",

doi = "10.1111/vco.12114",

language = "English (US)",

volume = "14",

pages = "e113--e125",

journal = "Veterinary and Comparative Oncology",

issn = "1476-5829",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Identification of drug-resistant subpopulations in canine hemangiosarcoma

AU - Khammanivong, A.

AU - Gorden, B. H.

AU - Frantz, A. M.

AU - Graef, A. J.

AU - Dickerson, E. B.

N1 - Funding Information: This work was partially supported by the Office of the Vice President for Research, University of Minnesota, award #21873 (E. B. D.), a Comparative Medicine Signature Program Pilot Grant through the University of Minnesota College of Veterinary Medicine (E. B. D.), and Morris Animal Foundation D13CA-0062 (E. B. D.). A. M. F. was supported by the DVM/PhD combined degree program of the College of Veterinary Medicine, University of Minnesota, by Morris Animal Foundation pre-doctoral fellowship D09CA-405, in part by funds from the Animal Cancer Care and Research Program, University of Minnesota, and by a doctoral dissertation fellowship from the Graduate School, University of Minnesota. This work also was supported in part by NIH P30 CA77598 utilizing the University Flow Cytometry Resource. Thanks to Jaime F. Modiano and Leslie C. Sharkey for the critical reading of this manuscript. Publisher Copyright: © 2014 John Wiley & Sons Ltd

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Canine hemangiosarcoma is a rapidly progressive disease that is poorly responsive to conventional chemotherapy. Despite numerous attempts to advance treatment options and improve outcomes, drug resistance remains a hurdle to successful therapy. To address this problem, we used recently characterized progenitor cell populations derived from canine hemangiosarcoma cell lines and grown as non-adherent spheres to identify potential drug resistance mechanisms as well as drug-resistant cell populations. Cells from sphere-forming cultures displayed enhanced resistance to chemotherapy drugs, expansion of dye-excluding side populations and altered ATP-binding cassette (ABC) transporter expression. Invasion studies demonstrated variability between cell lines as well as between sphere and monolayer cell populations. Collectively, our results suggest that sphere cell populations contain distinct subpopulations of drug-resistant cells that utilize multiple mechanisms to evade cytotoxic drugs. Our approach represents a new tool for the study of drug resistance in hemangiosarcoma, which could alter approaches for treating this disease.

AB - Canine hemangiosarcoma is a rapidly progressive disease that is poorly responsive to conventional chemotherapy. Despite numerous attempts to advance treatment options and improve outcomes, drug resistance remains a hurdle to successful therapy. To address this problem, we used recently characterized progenitor cell populations derived from canine hemangiosarcoma cell lines and grown as non-adherent spheres to identify potential drug resistance mechanisms as well as drug-resistant cell populations. Cells from sphere-forming cultures displayed enhanced resistance to chemotherapy drugs, expansion of dye-excluding side populations and altered ATP-binding cassette (ABC) transporter expression. Invasion studies demonstrated variability between cell lines as well as between sphere and monolayer cell populations. Collectively, our results suggest that sphere cell populations contain distinct subpopulations of drug-resistant cells that utilize multiple mechanisms to evade cytotoxic drugs. Our approach represents a new tool for the study of drug resistance in hemangiosarcoma, which could alter approaches for treating this disease.

KW - ABC transporter

KW - canine

KW - drug resistance

KW - hemangiosarcoma

KW - side population

UR - http://www.scopus.com/inward/record.url?scp=84980325817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84980325817&partnerID=8YFLogxK

U2 - 10.1111/vco.12114

DO - 10.1111/vco.12114

M3 - Article

C2 - 25112808

AN - SCOPUS:84980325817

VL - 14

SP - e113-e125

JO - Veterinary and Comparative Oncology

JF - Veterinary and Comparative Oncology

SN - 1476-5829

IS - 3

ER -

Identification of drug-resistant subpopulations in canine hemangiosarcoma

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this